We're excited to launch our new content series #GoodTrialsGrapevine in honor of #CTD2023, showcasing expert insights on key themes in clinical research; what makes a good trial & why.
Kicking off the series with a quote from healthcare veteran & business leader @DrAmritRay! 👇
Kudos to the team @FondationIpsen - for terrific work: Can alternative funding mechanisms help R&D and access for #Rarediseases ? https://t.co/O5xCBoQZmX
Join #ScienceWebinars for their last #ScienceAndLife webinar of the year on #RareDiseases:
The profoundly personal side of rare disease: Humanizing the therapeutic journey of patients
On Thursday, 10 November, 12 p.m. ET
Register today at https://t.co/NrXC9ulICg
#Webinar
@MartinLandray Congratulations @MartinLandray - extremely well deserved! Your impact on the public health and on your colleagues is remarkable and appreciated by so many of us.
Did you know that 70% of all deaths are due to noncommunicable diseases?
This Global Week for Action on #NCDs it's time to wake up and #ActOnNCDs
In this video @WHO Director-General @DrTedros explains how together we can #beatNCDs
📽️➡️ https://t.co/lXk2HYucAD
Don’t forget the pandemic of silent killers in the midst of the Covid-19 crisis #NCDs The emerging markets will bear a disproportionate burden unless they act now! #healthcare@DrKannanSydney@DrAmritRay https://t.co/KAqwlEYHh4
Upjohn, a division of Pfizer, is proud to partner with @ACCinTouch on this new #NCDAcademy initiative, bringing CVD and stroke prevention training to healthcare professionals around the world.
How do we tip the scales in the noncommunicable disease crisis? Upjohn, a division of Pfizer, is using an evidence-based approach to develop tailored solutions by market. Read more on reducing the risks of #NCDs: https://t.co/fFUcmV1EAE
#BioAsia2020 is gearing up! We are looking forward to having @DrAmritRay, Global President R&D & Medical, @pfizer with us. Join us as he speaks about global healthcare scenario with a focus on non-communicable diseases' increasing burden in India.
#TodayForTomorrow#AmritRay
Around the 🌎, the toll of #NCDs is unprecedented; they pose a crisis for patients, #publichealth & societies: https://t.co/0QjtcJJBEN @NCDAlliance#UNGA
Benefits & risks of innovation in clinical trials. Great discussion by John Alexander, Roger Lewis & Ted Lystig. Make sure you read to the bottom of Roger’s slide. @CTTI_Trials
The most undervalued professionals on the healthcare team is the #pharmacist. How they helped drive adherence for some of our sickest patients.
https://t.co/Z8zBhWomRH
#RareDiseaseDay2019#RareDiseaseDay is the official awareness-raising campaign for rare diseases. The objective is to raise awareness among the general public/decision-makers about #rarediseases & their impact on patients' lives. See campaign materials: https://t.co/CN9hzCbERw